Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Am J Clin Oncol. 2023 Aug 1;46(8):353-359. doi: 10.1097/COC.0000000000001014. Epub 2023 Jun 2.
Am J Clin Oncol. 2023.
PMID: 37264515
Clinical Trial.
Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies.
Fracasso PM, Westervelt P, Fears CL, Rosen DM, Zuhowski EG, Cazenave LA, Litchman M, Egorin MJ.
Fracasso PM, et al. Among authors: fears cl.
J Clin Oncol. 2000 Mar;18(5):1124-34. doi: 10.1200/JCO.2000.18.5.1124.
J Clin Oncol. 2000.
PMID: 10694566
Clinical Trial.
Item in Clipboard
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL.
Fracasso PM, et al. Among authors: fears cl.
Ann Oncol. 2002 Nov;13(11):1819-25. doi: 10.1093/annonc/mdf342.
Ann Oncol. 2002.
PMID: 12419757
Free article.
Clinical Trial.
Item in Clipboard
Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.
Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA.
Fracasso PM, et al. Among authors: fears cl.
Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547.
Cancer. 2003.
PMID: 12879480
Free article.
Clinical Trial.
Item in Clipboard
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
Fracasso PM, Goldstein LJ, de Alwis DP, Rader JS, Arquette MA, Goodner SA, Wright LP, Fears CL, Gazak RJ, Andre VA, Burgess MF, Slapak CA, Schellens JH.
Fracasso PM, et al. Among authors: fears cl.
Clin Cancer Res. 2004 Nov 1;10(21):7220-8. doi: 10.1158/1078-0432.CCR-04-0452.
Clin Cancer Res. 2004.
PMID: 15534095
Clinical Trial.
Item in Clipboard
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
Fracasso PM, Blum KA, Ma MK, Tan BR, Wright LP, Goodner SA, Fears CL, Hou W, Arquette MA, Picus J, Denes A, Mortimer JE, Ratner L, Ivy SP, McLeod HL.
Fracasso PM, et al. Among authors: fears cl.
Br J Cancer. 2005 Jul 11;93(1):46-53. doi: 10.1038/sj.bjc.6602653.
Br J Cancer. 2005.
PMID: 15942626
Free PMC article.
Clinical Trial.
Item in Clipboard
A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
Govindan R, Lim WT, Arquette MA, Goodner SA, Fears CL, Mortimer JE, Fracasso PM.
Govindan R, et al. Among authors: fears cl.
Oncol Rep. 2006 Jan;15(1):123-7.
Oncol Rep. 2006.
PMID: 16328044
Free article.
Clinical Trial.
Item in Clipboard
Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.
Fracasso PM, Blum KA, Tan BR, Fears CL, Bartlett NL, Arquette MA, Clark RS.
Fracasso PM, et al. Among authors: fears cl.
Cancer. 2002 Nov 15;95(10):2223-9. doi: 10.1002/cncr.10937.
Cancer. 2002.
PMID: 12412177
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite